Interventional Study of Vosoritide for the Treatment of Children With Hypochondroplasia
Clinical trial NCT06455059 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06455059
- Sponsor
- BioMarin Pharmaceutical
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-17
- Primary completion
- 2026-08-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.